KKKübra Saçar Kübüç

Kübra Saçar Kübüç

*This is an algorithmically generated author record based on publicly available information.

Kübra Saçar Kübüç has a total of 127 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Olgularla Yoğun Bakım II

    by Ahmet Bindal, Erkan Çakmak, Oya Olcay Özdeş, Tuğçe Gazioğlu Kişi, Özümcan Akkoç, E. Büşra Berilgen Kaya, Aysun Yıldız Altun, Havin Şahin, Rahmet Yıldırım, Canan Akman, et al.

  • Tüberküloz Menenjiti

    by Kübra Saçar Kübüç

    Tüberküloz menenjiti (TBM), merkezi sinir sisteminin en ağır ve en ölümcül tüberküloz formudur. Tüm tüberküloz olgularının yaklaşık %1’ini oluşturmasına rağmen mortalite oranı %15–40, kalıcı nörolojik sekel oranı ise %25–50 arasındadır. HIV enfeksiyonu, diyabet, ileri yaş, immünsüpresyon ve malnütrisyon başlıca risk faktörleridir. Olgu sunumunda 75 yaşında, diyabet ve kronik böbrek yetmezliği olan kadın hastada gelişen TBM ele alınmıştır. Hasta baş ağrısı, ateş ve bilinç bulanıklığı ile başvurmuş, ilerleyen süreçte entübe edilerek yoğun bakıma alınmıştır. Beyin omurilik sıvısında yüksek protein, düşük glukoz ve lenfosit baskın hücre artışı saptanmış; ARB negatif ancak TBC PCR pozitif bulunmuştur. Antitüberküloz tedavi ve kortikosteroid başlanmış, ancak septik şok gelişen hasta kaybedilmiştir. TBM patogenezinde hematojen yayılım ve meningeal inflamasyon rol oynar. Tanıda BOS incelemesi ve moleküler testler önemlidir. Erken tanı, uygun tedavi ve yoğun bakım desteği prognoz açısından kritik öneme sahiptir.

  • Open Access

    Cardiac tamponade due to internal jugular catheterization after lung resection: a rare but life-threatening complication (case report)

    by Süleyman Gökalp Güneş, Barış Gülmez, Kübra Saçar, Beniz İrEm Ersoy Şığva

    Internal jugular venous catheterization is an invasive procedure, and there are life-threatening complications that require urgent intervention. In this study, we present a young patient who developed myocardial injury due to internal jugular catheterization. The patient underwent middle lobectomy for bronchiectasis. Right internal jugular venous catheterization was performed. In the fourth postoperative hour, resuscitation was initiated due to sudden hypotension, tachycardia, and altered consciousness. Bedside echocardiography, performed to evaluate the etiology of the acute presentation, revealed diffuse fluid accumulation in the pericardial cavity. Following fluid drainage, hemodynamic stability was achieved. Possible complications can be life-threatening, and rapid diagnosis along with prompt treatment may be life-saving.

  • Interpretation of inflammatory markers in lung cyst hydatid disease

    by Barış Gülmez, S. Gökalp Güneş, Beniz İ. E. Şığva, Kübra Saçar, Bahar A. Şanlı, Abdullah Adıyaman

    Studies on alterations in inflammatory markers and risk factors for perforation in hydatid cysts of the lung are rare. In our study, we planned to investigate the effect of inflammatory markers on prognosis of hydatid cyst disease. 37 patients underwent surgery for pulmonary hydatid cyst between February 2022 and October 2023 and analyzed retrospectively. Inflammatory markers were calculated from preoperative and postoperative 3rd-month peripheral blood results. Cyst size was 58.5 ± 28.0 mm, 5 patients had bilateral cysts and 11 patients had multifocal cysts. Preoperative white blood cell, white blood cell difference, preoperative and postoperative eosinophils, preoperative neutrophils, neutrophils difference, preoperative systemic immune inflammatory index, systemic immune inflammatory index difference and preoperative eosinophil lymphocyte ratio were higher in patients with perforated cysts, the cut-off value for preoperative white blood cell for perforation was 10,535, preoperative cut-off value for eosinophils was 230, preoperative cut-off value for neutrophils was 8815, the cut-off value for preoperative systemic immune inflammatory index was 1129.83 and the cut-off value for preoperative eosinophil–lymphocyte ratio was 0.09. In patients with preoperative eosinophil, neutrophil, white blood cell, eosinophil–lymphocyte ratio and systemic immune inflammatory index values above the cut-off value, the probability of perforation increased 7.5, 13.6, 6.3, 9.6, and 9.3 times, respectively.


  • Open Access

    The Impact of CoronaVac Vaccination on 28-day Mortality Rate of Critically Ill Patients with COVID-19 in Türkiye

    by Fethi Gül, Umut Sabri Kasapoğlu, Mehmet Süleyman Sabaz, Pınar Ay, Burçin Doruk Oktay, Gülbahar Çalışkan, Nalan Demir, İsmet Sayan, Feyyaz Kabadayı, Gülsüm Altuntaş, et al.

    Background: Vaccines against coronavirus disease-19 (COVID-19) have been effective in preventing symptomatic diseases, hospitalizations, and intensive care unit (ICU) admissions. However, data regarding the effectiveness of COVID-19 vaccines in reducing mortality among critically ill patients with COVID-19 remains unclear.Aims: To determine the vaccination status and investigate the impact of the COVID-19 vaccine on the 28-day mortality in critically ill patients with COVID-19.Study Design: Multicenter prospective observational clinical study.Methods: This study was conducted in 60 hospitals with ICUs managing critically ill patients with COVID-19. Patients aged >= 18 years with confirmed COVID-19 who were admitted to the ICU were included. The present study had two phases. The first phase was designed as a one-day point prevalence study, and demographic and clinical findings were evaluated. In the second phase, the 28-day mortality was evaluated.Results: As of August 11, 2021, 921 patients were enrolled in the study. The mean age of the patients was 65.42 +/- 16.74 years, and 48.6% (n = 448) were female. Among the critically ill patients with COVID-19, 52.6% (n = 484) were unvaccinated, 7.7% (n = 71) were incompletely vaccinated, and 39.8% (n = 366) were fully vaccinated. A subgroup analysis of 817 patients who were unvaccinated (n = 484) or who had received two doses of the CoronaVac vaccine (n = 333) was performed. The 28-day mortality rate was 56.8% (n = 275) and 57.4% (n = 191) in the unvaccinated and two-dose CoronaVac groups, respectively. The 28-day mortality was associated with age, hypertension, the number of comorbidities, type of respiratory support, and APACHE II and sequential organ failure assessment scores (p < 0.05). The odds ratio for the 28-day mortality among those who had received two doses of CoronaVac was 0.591 (95% confidence interval: 0.413-0.848) (p = 0.004).Conclusion: Vaccination with at least two doses of CoronaVac within six months significantly decreased mortality in vaccinated patients than in unvaccinated patients.


  • Open Access

    Infections that may be missed during the COVID-19 pandemic, legionella pneumophila infection: A case report

    by Mehmet Kilic, Kübra Saçar Kubuc, Esra Gurbuz, Abdusselam Ozdemir

    During pandemics, certain uncommon diseases might manifest within vulnerable populations. An example is Legionella spp, an aerobic, gram-negative pathogen that can thrive intracellularly. This microorganism holds significance for public health, being responsible for both pneumonia acquired in community settings and healthcare settings. Among Legionella cases, Legionella pneumophila accounts for about 90% of them. When observing coronavirus disease 2019 (COVID-19) patients in the intensive care unit, it's crucial to consider Legionella as a possible alternative diagnosis due to its similar clinical manifestations. In this case report, we aim to highlight a 43-year-old male patient, previously without any chronic conditions, who was initially diagnosed with COVID-19 but later identified to have Legionella pneumonia , presenting with symptoms including confusion, dysarthria, weakness, pain, and respiratory failure upon hospital admission.